Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders

BACKGROUND: Few data are available regarding the use of direct antiviral agents (DAAs) for chronic hepatitis C in psychiatric patients. The aim of the study is to assess safety and outcome of DAAs in patients with psychiatric comorbidities. METHODS: This retrospective, observational, single-centre s...

Descripción completa

Detalles Bibliográficos
Autores principales: de Gennaro, Nicolò, Diella, Lucia, Monno, Laura, Angarano, Gioacchino, Milella, Michele, Saracino, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059311/
https://www.ncbi.nlm.nih.gov/pubmed/32138757
http://dx.doi.org/10.1186/s12879-020-4922-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059311/
https://www.ncbi.nlm.nih.gov/pubmed/32138757
http://dx.doi.org/10.1186/s12879-020-4922-2

Ejemplares similares